If you found any interesting story and want to share with us, please drop the PubMed pmid or title of the paper by replying to the 'comments'. I will 'lift' it to the post content, assign an id and make link for the paper. Thank you. Su-Fang
Identification of an Early Unipotent Neutrophil Progenitor with Pro-tumoral Activity in Mouse and Human Bone Marrow. (2018/08 Cell Rep)
A New Perspective: Exploring Future Therapeutic Strategies For Cancer By Understanding The Dual Role Of B Lymphocytes In Tumor Immunity. (2018/ Int J Cancer)
IFNg-Dependent Tissue-Immune Homeostasis Is Co- opted in the Tumor Microenvironment (2017/06 Cell)
Targeting tumor-infiltrating Ly6G1 myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma (2017/12 Int J Cancer, NTUH)
Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment (2018/01 J Immunol)
Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients. (2017/12 J Pathol)
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient (2017/08 Cell )
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution (2017/11 Cell)
MHC-I Genotype Restricts the Oncogenic Mutational Landscape (2017/11 Cell)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy (2017/12 Science)
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts (2017/12 Cell Reports)
Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases (2017/12 Oncogene)
An immunogenic personal neoantigen vaccine for patients with melanoma (cancer vaccine 1/2, Catherine Wu group 28678778)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer (cancer vaccine 2/2, Ugur Sahin group 28678784)
An immune atlas of clear cell renal cell carcinoma (using CyTOF to detect TILs 28475899)
Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses (using scRNA-seq to detect TILs 28475900)
麗蓉老師推薦 Effective combinatorial immunotherapy for castration-resistant prostate cancer (Ronald A. DePinho 且有 CyTOF) (28321130) (Erratum)
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. (11323675)
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. (25893296)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma. (27265504)
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer. (27713748)
-------------------------------------------------------- 2014/06/20 咦, 有PubPeer alert呦... Christos Chinopoulos | Jun 20 2014 05:48 EST
Could it be that LPS-induced succinate over-production is due to itaconate formation? LPS induces Irg1, a gene coding for cis-aconitate decarboxylase, specifically expressed in cells of macrophage lineage Proc Natl Acad Sci U S A. 2013 May 7;110(19):7820-5. doi: 10.1073/pnas.1218599110, yielding itaconate. Itaconate is preferentially used by succinyl CoA ligase forming itaconyl CoA, thus generating an accumulation of succinate when the ligase operates towards succinyl CoA formation ADLER J, WANG SF, & Lardy HA (1957) The metabolism of itaconic acid by liver mitochondria. J. Biol. Chem, 229, 865-879, and WANG SF, ADLER J, & Lardy HA (1961) The pathway of itaconate metabolism by liver mitochondria. J. Biol. Chem, 236, 26-30. http://www.ncbi.nlm.nih.gov/pubmed/23535595#cm23535595_4939
因此,剩下的唯一可能應是使用diethylsuccinate(DS)和butylmalonate(BM)所造成的差異。例如,BM除了induce HIF1A stabilization以外,還有stabilize其它IL1B之上游分子,而那些因子在DS那一組並未出現。如此便可解釋為何HIF1A和IL1B在兩種藥處理下,蛋白量並未成正相關。 How do you like this idea, Yi-Hong? 😀